Elective removal of metalwork following Lisfranc injury fixation: Results of a national consensus survey of practice.


Journal

Foot (Edinburgh, Scotland)
ISSN: 1532-2963
Titre abrégé: Foot (Edinb)
Pays: Scotland
ID NLM: 9109564

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 18 12 2020
revised: 07 04 2021
accepted: 12 04 2021
pubmed: 5 5 2021
medline: 26 10 2021
entrez: 4 5 2021
Statut: ppublish

Résumé

No consensus exists regarding whether metalwork should be routinely removed following fixation of a Lisfranc injury. When metalwork is removed, notable variation in the timing of surgery is reported in current literature. With the support of the British Orthopaedic Foot & Ankle Society (BOFAS) and the Orthopaedic Trauma Society (OTS) an online 10-question survey was distributed and completed by a total of 205 consultant surgeons in the UK between April-June 2020. Excluding the 20 consultant responses from a regional pilot survey, 185 responses were used to form the main analysis. Over one third (69/183, 37.7%) of surgeons reported they routinely remove metalwork following Lisfranc injury fixation at a median time of 6 months post fixation (interquartile range 4-10). The two most commonly chosen reasons for removal of metalwork were 'to optimise physiological function' and 'to reduce the risk of broken metalwork and risk of making subsequent surgery more difficult' (55/78 responses, 70.5%). Over two thirds of survey respondents (126/184, 68.5%) expressed interest to participate in a randomised controlled trial to compare outcomes of metalwork retention versus removal following Lisfranc injury fixation. Community clinical equipoise exists nationally regarding routine metalwork removal following Lisfranc injury fixation. Considering the paucity of literature, the current survey supports the development of a randomised controlled trial to establish the risks and benefits of metalwork retention versus removal, and would be of value to foot & ankle and trauma surgeons in the UK.

Identifiants

pubmed: 33946003
pii: S0958-2592(21)00037-7
doi: 10.1016/j.foot.2021.101811
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101811

Informations de copyright

Crown Copyright © 2021. Published by Elsevier Ltd. All rights reserved.

Auteurs

Amanda Rhodes (A)

Hampshire Hospitals NHS Foundation Trust, Department of Trauma & Orthopaedics, Aldermaston Road, Basingstoke, RG24 9NA, England, UK. Electronic address: amandarhodes@doctors.org.uk.

Robin Elliot (R)

Hampshire Hospitals NHS Foundation Trust, Department of Trauma & Orthopaedics, Aldermaston Road, Basingstoke, RG24 9NA, England, UK. Electronic address: robin.elliot@hhft.nhs.uk.

Daniel Marsland (D)

Hampshire Hospitals NHS Foundation Trust, Department of Trauma & Orthopaedics, Aldermaston Road, Basingstoke, RG24 9NA, England, UK. Electronic address: daniel.marsland@hhft.nhs.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH